DOW vs NGNE · P/E 74, rev $39.97B vs $286.5M cap
Dow Inc (DOW) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. NGNE currently screens at market cap $286.5M.
Not investment advice. Open the DOW and NGNE stock pages for the full models.
Not investment advice.